Voyager Therapeutics Inc VYGR

NAS: VYGR | ISIN: US92915B1061   12/11/2024
6,830 USD (-2,57%)
(-2,57%)   12/11/2024

18 maart 2021 · SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Voyager Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - VYGR · Persbericht

12 maart 2021 · INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm · Persbericht

12 maart 2021 · SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Voyager Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - VYGR · Persbericht

9 maart 2021 · ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors With Large Losses to Secure Counsel Before Important March 24 Deadline - VYGR · Persbericht

3 maart 2021 · SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Voyager Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - VYGR · Persbericht

26 februari 2021 · VYGR BREAKING NEWS: ROSEN, A TOP RANKED LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline - VYGR · Persbericht

25 februari 2021 · Voyager Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Corporate Updates · Persbericht

25 februari 2021 · INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm · Persbericht

19 februari 2021 · SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Voyager Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - VYGR · Persbericht

18 februari 2021 · Voyager Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Participate in Upcoming Investor Conference · Persbericht

7 februari 2021 · BREAKING NEWS: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Voyager Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline - VYGR · Persbericht

2 februari 2021 · Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program · Persbericht

30 januari 2021 · BREAKING NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors with Large Losses to Secure Counsel Before Important Deadline - VYGR · Persbericht

29 januari 2021 · Moore Kuehn, PLLC Encourages Investors of VYGR, TILE, or SWI to Contact Law Firm · Persbericht

27 januari 2021 · SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm · Persbericht

26 januari 2021 · VYGR Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc. Shareholders of Class Action and Encourages Shareholders to Contact the Firm · Persbericht

23 januari 2021 · Pomerantz Law Firm Announces the Filing of a Class Action against Voyager Therapeutics, Inc. and Certain Officers - VYGR · Persbericht

11 januari 2021 · Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

Mijn selecties